BIO’s messy transition, mRNA’s future, & Biogen’s next CEO

What’s going on at biotech’s lobbying organization? Where does mRNA go from here? And what happens when startups close down?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain the abrupt departure of the CEO of BIO, the lobbying group representing biotech on Capitol Hill, and its wider implications. We also discuss the latest news in the life sciences, including the future of mRNA, a promising startup closing its doors, and Biogen’s search for a new CEO.

For more on what we cover, here’s the latest on BIO; here’s the news from Moderna; here’s more on BioNTech; here’s the story on Triplet Therapeutics; here’s the latest on Biogen’s CEO search; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the Covid-19 pandemic.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].